mTOR Signaling in Metabolism and Cancer

The mechanistic/mammalian target of rapamycin (mTOR), a serine/threonine kinase, is a central regulator for human physiological activity. Deregulated mTOR signaling is implicated in a variety of disorders, such as cancer, obesity, diabetes, and neurodegenerative diseases. The papers published in thi...

সম্পূর্ণ বিবরণ

সংরক্ষণ করুন:
গ্রন্থ-পঞ্জীর বিবরন
বিন্যাস: Online
ভাষা:ইংরেজি
প্রকাশিত: MDPI - Multidisciplinary Digital Publishing Institute 2021
বিষয়গুলি:
অনলাইন ব্যবহার করুন:ONIX_20210501_9783039435531_1116
ট্যাগগুলো: ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
_version_ 1869521070170570752
collection Directory of Open Access Books
description The mechanistic/mammalian target of rapamycin (mTOR), a serine/threonine kinase, is a central regulator for human physiological activity. Deregulated mTOR signaling is implicated in a variety of disorders, such as cancer, obesity, diabetes, and neurodegenerative diseases. The papers published in this Special Issue summarize the current understanding of the mTOR pathway and its role in the regulation of tissue regeneration, regulatory T cell differentiation and function, and different types of cancer including hematologic malignancies, skin, prostate, breast, and head and neck cancer. The findings highlight that targeting mTOR pathway is a promising strategy to fight against certain human diseases.
format Online
id doab-20.500.12854ir-69370
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-693702024-03-30T23:22:47Z mTOR Signaling in Metabolism and Cancer Huang, Shile mTOR histone deacetylase prostate cancer integrins adhesion invasion cell metabolism T cells Foxp3 Acute Lymphoblastic leukemia targeted therapy metabolism cell signalling mTOR signalling head and neck cancer mutant genes biomarkers targeted therapies clinical trials cancers inhibitors photodynamic therapy PI3K Akt skin cancers phytochemicals melanoma basal cell carcinoma squamous cell carcinoma Merkel cell carcinoma TNBC eribulin PI3K/AKT/mTOR everolimus combination synergy mTOR signaling tissue regeneration neuron muscle liver intestine hematologic malignancies regulatory T cells tumor thema EDItEUR::M Medicine and Nursing The mechanistic/mammalian target of rapamycin (mTOR), a serine/threonine kinase, is a central regulator for human physiological activity. Deregulated mTOR signaling is implicated in a variety of disorders, such as cancer, obesity, diabetes, and neurodegenerative diseases. The papers published in this Special Issue summarize the current understanding of the mTOR pathway and its role in the regulation of tissue regeneration, regulatory T cell differentiation and function, and different types of cancer including hematologic malignancies, skin, prostate, breast, and head and neck cancer. The findings highlight that targeting mTOR pathway is a promising strategy to fight against certain human diseases. 2021-05-01T15:48:04Z 2021-05-01T15:48:04Z 2020 book ONIX_20210501_9783039435531_1116 9783039435531 9783039435548 https://directory.doabooks.org/handle/20.500.12854/69370 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/3163 https://mdpi.com/books/pdfview/book/3163 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-03943-554-8 10.3390/books978-3-03943-554-8 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783039435531 9783039435548 204 Basel, Switzerland open access
spellingShingle mTOR
histone deacetylase
prostate cancer
integrins
adhesion
invasion
cell metabolism
T cells
Foxp3
Acute Lymphoblastic leukemia
targeted therapy
metabolism
cell signalling
mTOR signalling
head and neck cancer
mutant genes
biomarkers
targeted therapies
clinical trials
cancers
inhibitors
photodynamic therapy
PI3K
Akt
skin cancers
phytochemicals
melanoma
basal cell carcinoma
squamous cell carcinoma
Merkel cell carcinoma
TNBC
eribulin
PI3K/AKT/mTOR
everolimus
combination
synergy
mTOR signaling
tissue regeneration
neuron
muscle
liver
intestine
hematologic malignancies
regulatory T cells
tumor
thema EDItEUR::M Medicine and Nursing
mTOR Signaling in Metabolism and Cancer
title mTOR Signaling in Metabolism and Cancer
title_full mTOR Signaling in Metabolism and Cancer
title_fullStr mTOR Signaling in Metabolism and Cancer
title_full_unstemmed mTOR Signaling in Metabolism and Cancer
title_short mTOR Signaling in Metabolism and Cancer
title_sort mtor signaling in metabolism and cancer
topic mTOR
histone deacetylase
prostate cancer
integrins
adhesion
invasion
cell metabolism
T cells
Foxp3
Acute Lymphoblastic leukemia
targeted therapy
metabolism
cell signalling
mTOR signalling
head and neck cancer
mutant genes
biomarkers
targeted therapies
clinical trials
cancers
inhibitors
photodynamic therapy
PI3K
Akt
skin cancers
phytochemicals
melanoma
basal cell carcinoma
squamous cell carcinoma
Merkel cell carcinoma
TNBC
eribulin
PI3K/AKT/mTOR
everolimus
combination
synergy
mTOR signaling
tissue regeneration
neuron
muscle
liver
intestine
hematologic malignancies
regulatory T cells
tumor
thema EDItEUR::M Medicine and Nursing
topic_facet mTOR
histone deacetylase
prostate cancer
integrins
adhesion
invasion
cell metabolism
T cells
Foxp3
Acute Lymphoblastic leukemia
targeted therapy
metabolism
cell signalling
mTOR signalling
head and neck cancer
mutant genes
biomarkers
targeted therapies
clinical trials
cancers
inhibitors
photodynamic therapy
PI3K
Akt
skin cancers
phytochemicals
melanoma
basal cell carcinoma
squamous cell carcinoma
Merkel cell carcinoma
TNBC
eribulin
PI3K/AKT/mTOR
everolimus
combination
synergy
mTOR signaling
tissue regeneration
neuron
muscle
liver
intestine
hematologic malignancies
regulatory T cells
tumor
thema EDItEUR::M Medicine and Nursing
url ONIX_20210501_9783039435531_1116